Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI
Alex Zhavoronkov, PhDDedicated to extending healthy productive life for everyone on the planet. Covers advances in longevity, AI, robotics, cryonics, quantum, and other emerging technologies. Posts are strictly personal, not reflective of positions of Insilico Medicine.
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 26 | Founded | 2 years ago | Last Issue | 14 days ago |
| Active | |||||
Read this Newsletter
forever.aiLatest Issues
Potential Longevity Therapeutics: TEAD inhibitors and their role in cancer, fibrosis, and aging
For over two decades in this field, I have watched the pharmaceutical industry treat certain targets the way a sailor treats a reef: charted, feared, and given a wide berth. TEAD is one of those reefs. It sits at the bottom of one of the mo...
AI Drug Discovery Dreams: How Fast Can an AI-Discovered Drug Be Approved?
Disclaimer: A disclaimer before you read further: these are my own hypothetical thoughts. They do not reflect the position, research, or work of my company or any of its partners. I used AI model orchestration to estimate the timelines, so...
Can We Accelerate Drug Discovery and Longevity Research by Replacing/Augmenting IND-Enabling Studies With Human Volunteers in Emerging Geographies?
TL;DR: “For super-safe drugs, and above all for longevity therapeutics that must be safe by definition, we can treat the first human dose after non-GLP toxisity studies and give a year back to patients.”
Disclaimer: A disclaimer before you...
Can We Use Longevity to Achieve Global Peace?
On September 3, 2025, during a military parade in Beijing, a hot microphone captured a brief exchange between two world leaders. The remark that traveled fastest was a simple observation that in this century humans may live to 150, and that...
How Long Can Elon Live, and Stay Productive?
Like millions of others, I was offered by my bank the chance to buy into the IPO of SpaceX. I put in nominal capital, not as an investment but as a small wager on the convergence of intelligence and machinery these companies represent, and...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI.
| Subscribers | Engagement | 78 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Alex Zhavoronkov, PhD, is CEO of Insilico Medicine (HKEX:3696), a generative AI biotech, which nominated 30+ preclinical candidates and got into clinical trials. He's also an adjunct professor at the Buck Institute for Aging.
Frequently Asked Questions
How can I access the email archive for this newsletter?
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does this newsletter have?
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in this newsletter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like this newsletter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to this newsletter?
Scroll up to where it says Related Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact this newsletter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.